Probably, CXCR2 positive ovarian cancer cells could potentiate the NF-κB mediated CCL20 in proinflammatory tumor microenvironment via interaction between ovarian cancer and cancer-associated stromal cells compared to CXCR2 negative cells (Fig 6D). The gene discussed is CXCR2; the disease is ovarian carcinoma.